Cardiovascular Disease Risk Among Transgender People with HIV
Madeline Cetlin(Harvard University), Mabel Toribio(Boston College), Sarah M Chu(Harvard University), Markella V. Zanni(Harvard University), Ole‐Petter R. Hamnvik(Brigham and Women's Hospital), Tonia Poteat(Duke University), Evelynne S. Fulda(Cancer Research And Biostatistics)
Cited by 7
Related Papers
Leptin in human physiology and pathophysiology
|American Journal of Physiology-Endocrinology and Metabolism|2011|582
The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
|JACC Heart Failure|2018|498
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
|New England Journal of Medicine|2023|476
Arterial Inflammation in Patients With HIV
|JAMA|2012|464
TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2010|320